Future Horizons and Growth Strategies in the Global Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts

Date: June 16, 2015
Pages: 1200
Price:
US$ 34,750.00
License [?]:
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: TD02DF3A78AEN
Leaflet:

Download PDF Leaflet

Future Horizons and Growth Strategies in the Global Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts
Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years - Examines trends in the U. S., Europe and Japan - Reviews current and emerging tumor markers - Analyzes applications of emerging diagnostic technologies - Forecasts sales of major tumor markers by country and market segment - Profiles leading market players and potential entrants - Suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide. Geographic Coverage - France - Germany - Italy - Japan - Spain - UK - USAMarket Segmentation Analysis - Sales and market shares of major suppliers, by individual tumor marker and country. - Five - year test volume and sales forecasts for major tumor markers by country and market segment, including: - Hospitals - Commercial/Private Laboratories - Physician Offices/Group Practices
  • Cancer Clinics - Ambulatory Care Centers - Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.
  • Cancer statistics, etiology and recent developments in the U. S., Japan and five major European countries. Current and Emerging Products - Review of over 200 current and emerging tumor markers, including: - Biochemical Markers - Oncogenes - Growth Factors - Hormones - Colony Stimulating Factors - Lymphokines - Immunohistochemical Stains, and others. - Analysis of major immunoassay analyzers used for tumor marker testing, including their operating characteristics, features and selling prices. Technology Review - Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and their potential applications for tumor marker testing. - Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy. - Extensive listings of over 500 companies, universities and research centers developing new tumor markers and detection technologies.

    Competitive Assessments

    Extensive strategic assessments of major suppliers and start - up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. Worldwide Market Overview - Estimated universe of laboratories performing tumor marker testing by country. - Ten - year test volume and sales projections by country. Business

    Opportunities and Strategic Recommendations

    Specific new product development opportunities with potentially significant market appeal during the next ten years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. MethodologyThis report is based on interviews with clinical pathologists, laboratory directors, executives from leading diagnostic companies and start - up firms developing innovative products, university scientists, as well as experts from industry associations, venture capital firms and the investment banking community in the U. S., five major European countries and Japan. The market projections are also based on questionnaire responses received from hospitals, commercial/private laboratories, physician offices/group practices, cancer clinics and ambulatory care centers in seven countries. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product literature, patents, trade association surveys, government studies, marketing and technical meeting presentations, industry analyst reports, and VPGMarketResearch's proprietary data files was conducted.

    Contains 1,200 pages and 450 tables
  • INTRODUCTION

    WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

    A. Cancer Statistics and Etiology
      1. Brest Cancer
      2. Lung Cancer
      3. Colon and Rectum Cancer
      4. Prostate Cancer
      5. Stomach Cancer
      6. Leukemia
      7. Lymphoma
      8. Oral Cancer
      9. Skin Cancer
      10. Uterine Cancer
      11. Ovarian Cancer
      12. Bladder Cancer
    B. Major Current And Emerging Cancer Diagnostic Tests
      1. Introduction
      2. Tumor Marker Classification
      3. ACTH
      4. Alpha-Fetoprotein (AFP)
      5. Beta-2 Microglobulin
      6. CA 15-3/27.29
      7. CA 19-9
      8. CA-125
      9. Calcitonin
      10. Carcinoembrionic Antigen (CEA)
      11. Estrogen and Progesterone Receptors
      12. Ferritin
      13. Gastrin
      14. Human Chorionic Gonadotropin (HCG)
      15. Insulin
      16. NSE
      17. Occult Blood
      18. PAP Smear/HPV
      19. Prostatic Acid Phosphatase (PAP)
      20. Prostate-Specific Antigen (PSA)
      21. Squamous Cell Carcinoma Antigen (SCC)
      22. T and B Lymphocytes
      23. TdT
      24. Thyroglobulin
      25. Tissue Polypeptide Antigen (TPA)
      26. Biochemical Tumor Markers
        ADA
        B-Protein
        PNP
        5'-Nucleotidase
      27. Oncogenes
        Abl/abl-bcr
        AIB1
        BCL-2
        BRCA1
        CD44
        C-fos
        C-myb
         C-myc
        CYP-17
        Erb-B
        HPC1
        N-myc
        P40
        P51
        P53
        PIK3CA
        PTI-1
        Ras
        Reg
        Sis
        Src
      28. Polypeptide Growth Factors
        Basic Fibroblast Growth Factor
        Beta-TGF
        Cachectin (TNT)
        Calmodulin
        ECFR
        Nerve Growth Factor (NGF)
        Epidermal Growth Factor (EGF)
        Ornithine Decarboxylase
        Transferrin
        Transforming Growth Factor-Alpha
      29. Ectopic Hormones
      30. Colony Stimulating Factors
      31. Lymphokines
        Alpha-Interferon
        B Cell Growth Factors
        B Cell Growth Factor (BCGF)
        Gamma-Interferon
        Interleukin-1 (IL-1)
        Macrophage Activating Factor
      32. Immunohistochemical Stains
      33. Emerging Tumor Markers
        N-Acetylglucosamine
        Actin
        Alpha-Actin
        Antineuronal Antibodies
        7B2
        B72.3
        Bax
        BCD-F9
        BLCA-4
        Blood Group Antigens A,B,H
        CA 50
        CA 72-4/TAG-72
        CA 195
        CA-242
        CA-549
        CAM 26
        CAR-3
        Cathepsin-D
        Chromogranin A and B
        Cluster 1 Antigen
        Cluster-5/5A Antigen
        CTA
        CU18
        DR-70
        DU-PAN-2
        Endometrial Bleeding Associated Factor
        Endostatin
        Epithelial Membrane Antigen
        Feulgen Hydrolysis
        Fibronectin
        FSH
        (1->3)-L-fucosyltransferase
        Gastrin-Releasing Peptide (GRP)
        GDCFP-15
        Glucagon
        Glycoamines
        H23
        Her-2
        Human Carcinoma Antigen
        HPA
        HSP27
        Intermediate Filaments
        Cytokeratins/CK18/Cyfra 21-1
        Desmin
        Gliofibrillary Acid Protein
        Neurofilaments
        Vimentin
        KA 93
        Kinases
        KP16D3
        LAI
        Leukocyte Common Antigen
         Lewis Antigens
        Lysophosphatidic Acid (LPA)
        Ma 695/Ma 552
        MABDF3
        MAG
        ME1
        Minactivin
        MN/CA9
        MSA
        Mucin Cancer Antigen (MCA)
        Multiple Tumor Suppressor 1
        Myosin
        NEA-130
        NMP22
        OA-519
        Opiod Peptides
        P-glycoprotein
        Pancreatic Oncofetal Antigen (POA)
        Placental Lactogen
        PR92
          Proliferative Index, Ki-67
        Px
        RB Inactivation/Deletion
        Ret
        SCCL 175
        Selectin
        Sialic Acid
        Sialyl SSEA-1/SLX
        SN10
        Somatostatin
        TA-90
        TABA
        Tachykinin
        TAG 12
        TPS
        Troponin
        Tubulin
        VCAM
        VEGF
      Villen
    C. Instrumentation Review And Market Needs
      1. Abbott AxSYM
      2. Abbott Architect c4000
      3. Abbott Architect i2000 Series
      4. Abbott Architect ci8200 System
      5. Beckman Coulter UniCel Series
      6. Beckman Coulter Access
      7. Binding Site ESP600
      8. bioMerieux Mini Vidas
      9. Carolina Chemistries BioLis 24i
      10. DiaSorin Liaison
      11. Horiba ABX Pentra 400
      12. Inverness DS2
      13. J&J Vitros ECi/ECiQ
      14. J&J Vitros 3600
      15. J&J Vitros 5600
      16. Olympus AU5400
      17. Olympus AU3000i
      18. Olympus AU2700
      19. Roche Modular Analytics
      20. Roche Cobas Integra 400
      21. Roche Cobas Integra 400 Plus
      22. Roche Elecsys
      23. Roche Cobas c311
      24. Siemens ADVIA Centaur
      25. Siemens Dimension
      26. Siemens Dimension RxL Max
      27. Siemens Dimension Vista 500
      28. Siemens Immulite
      29. Siemens Stratus
      30. Tosoh AIA-Series
      31. Vital Diagnostics ATAC 8000
      32. Vital Diagnostics Envoy 500
    D. Current and Emerging Technologies
      1. Monoclonal and Polyclonal Antibodies
      2. Immunoassays
        a. Technological Principle
        b. Radioimmunoassay (RIA)
        c. Enzyme Immunoassays (EIA)
          Overview
          ELISA
          Immunofiltration
          Particle-Membrane Capture Immunoassay
          Enzyme Amplification
        d. Fluorescent Immunoassays
        e. Luminescence
          Chemiluminescence
          Bioluminescence
        f. Latex Agglutination
        g. Immunoprecipitation
        h. Affinity Chromatographu
        e. Liposome Flow-Injection Immunoassay
      3. Molecular Diagnostics
        a. Technology Overview
        b. Amplification Methods
          PCR
          DAP-PCR
          Immuno-PCR
          QC-PCR
          CAR
          DNA
          HPA
          LCR
          NASBA
          QBR
          SDA
          3 SR, and others
      4. Chromosome Analysis
        a. Chronic Myelogenous Leukemia (CML)
        b. Acute Myeloid Leukemia (AML)
        c. Acute Lymphoblastic Leukemia (ALL)
        d. Malignant Lymphomas Lymphoid Malignancies
        e. Chronic Lymphocytic Leukemia (CLL)
        f. Solid Cancers
        g. Chromosomal Translocation and Oncogenes
      5. Artificial Intelligence
      6. Flow Cytometry
      7. Two Dimensional Gel Electrophoresis (2-DGE)
      8. Biosensors
      9. Competing/Complementing Technologies
        a. CT
        b. MRI
        c. NMR
        d. PET
        e. Photonics Spectroscopy
    F. Business Environment
      1. Market Overview
      2. Worldwide Market Structure
      3. Worldwide Market Size and Growth
    G. Personal Testing

    FRANCE

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Growth and Major Suppliers

    GERMANY

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Growth and Major Suppliers

    ITALY

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Growth and Major Suppliers

    JAPAN

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Growth and Major Suppliers

    SPAIN

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Growth and Major Suppliers

    U.K.

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Growth and Major Suppliers

    U.S.A.

    A. Executive Summary
    B. Business Environment
      1. Health Care Expenditures
      2. Cost Consciousness
      3. Industry Consolidation
      4. Managed Care
      5. Hospitals
      6. Admissions
      7. Length of Stay
      8. Industry Diversification
      9. Physician Demographics
      10. Population Aging
        a. Chronic Illness
        b. Disease Incidence
        c. Susceptibility to Iatrogenesis
        d. Multiple Illness Cases
      11. Laboratory Regulations
    C. Market Structure
      1. Centralized Testing
        a. Hospitals
        b. Commercial/Private Laboratories
    2. POT/Decentralized Testing
        a. Physician Offices/Group Practices
        b. Cancer Clinics
        c. Point-Of-Care Testing
        d. Other Decentralized Testing Locations
    D. Market Size, Growth and Major Suppliers Sales, Instrument Placements and Market Shares

    MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    A. Reagent Kits and Test Systems/Panels
    B. Instrumentation
    C. Computers, Software and Automation
    D. Auxiliary Products

    DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies
      1. Marketing Approaches
      2. Product Complexity
      3. Customer Preference
      4. Established Suppliers
      5. Emerging Suppliers
      6. Major Types of Distributors
      7. Market Segmentation Factor

    POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    COMPETITIVE PROFILES

    Abbott
    AdnaGen
    Applied Gene Technologies
    Arca
    Beckman Coulter/Danaher
    Becton Dickinson
    Biomedical Diagnostics
    bioMerieux
    Bio-Rad
    Cepheid
    Correlogic Systems
    Dako
    Decode
    Diadexus
    Diagnocure
    Diasorin
    Eiken Chemical
    Enterix
    Enzo Biochem
    Epigenomics
    Exact Sciences
    Fujirebio
    Gen-Probe
    Guided Therapeutics
    Hologic
    Ipsogen
    Kreatech
    Kyowa Medex
    Life Technologies
    Mackay Life Sciences
    Myriad Genetics
    Nanogen Elitech
    OncoLab
    Otho-Clinical Diagnostics
    Panacea Pharmaceuticals
    Polartechnics
    Polymedco
    PreMD
    Qiagen
    Radient Pharmaceuticals
    Roche
    Scienion
    Sequenom
    Siemens Healthcare
    Takara Bio
    Targeted Diagnostics & Therapeutics
    Tosoh
    Veridex
    Wako Pure Chemicals
    Wallac/PE
    Zila

    APPENDIXES

    Appendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technology and Applications
    Appendix II: Assumed Currency Exchange Rates

    LIST OF TABLES

    Tumor Marker Classification
    Major Companies Developing or Marketing ACTH Tests
    Major Companies Developing or Marketing AFP Tests
    Major Companies Developing or Marketing Beta-2 Microglobulin Tests
    Major Companies Developing or Marketing CA 15-3/27.29 Tests
    Major Companies Developing or Marketing CA 19-9 Tests
    Major Companies Developing or Marketing CA 125 Tests
    Major Companies Developing or Marketing Calcitonin Tests
    Major Companies Developing or Marketing CEA Tests
    Major Companies Developing or Marketing Estrogen Receptor Tests
    Major Companies Developing or Marketing Progesterone Receptor Tests
    Major Companies Developing or Marketing Ferritin Tests
    Major Companies Developing or Marketing Gastrin Tests
    Major Companies Developing or Marketing HCG Tests
    Major Companies Developing or Marketing Insulin Tests
    Major Companies Developing or Marketing NSE Tests
    Major Companies Developing or Marketing Occult Blood Tests
    Major Companies Developing or Marketing PAP Smear/HPV Tests
    Major Companies Developing or Marketing PAP Tests
    Major Companies Developing or Marketing PSA Tests
    Major Companies Developing or Marketing Lymphocyte Subclassification Tests
    Biochemical Markers Potential Applications In Cancer Diagnosis
    Oncogenes Potential Applications In Cancer Diagnosis
    Major Companies Developing or Marketing Oncogene Tests
    Growth Factors Potential Applications In Cancer Diagnosis
    Colony Stimulating Factors Potential Applications in Cancer Diagnosis
    Lymphokines Potential Applications In Cancer Diagnosis
    Immunohistochemical Stains Potential Applications in Cancer Diagnosis
    Executive Summary Table: France, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
    France, Estimated Cancer Death Rates Per 100,000 Population
    France, Laboratories Performing Tumor Marker Tests by Market Segment
    France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
    France, Total Tumor Marker Test Volume Forecast by Market Segment
    France, All Market Segments Major Tumor Marker Test Volume Forecast
    France, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
    France, Commercial/Private Laboratories Tumor Marker Test Volume Forecast
    France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
    France, All Market Segments Major Tumor Marker Sales Forecast by Test
    France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
    France, Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
    France, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    France, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
    France, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market
    France, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
    France, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
    France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    France, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
    France, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
    France, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    France, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
    France, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    France, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Thymidine Kinase Test Volume And Diagnostics Sales Forecast by Market Segment
    France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    France, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Total Tumor Marker Sales By Major Suppliers
    France, AFP Testing Market Diagnostics Sales by Major Supplier
    France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
    France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
    France, CA 125 Testing Market Diagnostics Sales by Major Supplier
    France, CEA Testing Market Diagnostics Sales by Major Supplier
    France, NSE Testing Market Diagnostics Sales by Major Supplier
    France, PAP Testing Market Diagnostics Sales by Major Supplier
    France, PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment
    Germany, Estimated Cancer Death Rates Per 100,000 Population
    Germany, Laboratories Performing Tumor Marker Tests by Market Segment
    Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
    Germany, Total Tumor Marker Test Volume Forecast by Market Segment
    Germany, All Market Segments, Major Tumor Marker Test Volume Forecast
    Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Test
    Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
    Germany, Total Tumor Marker Sales Forecast by Market Segment
    Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
    Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
    Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
    Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
    Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, CA-19 Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Calcitonin Test Volume And Diagnostic Sales Forecast by Market Segment
    Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
    Germany, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
    Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
    Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
    Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Total Tumor Marker Sales By Major Supplier
    Germany, AFP Testing Market Diagnostics Sales by Major Supplier
    Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
    Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
    Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
    Germany, CEA Testing Market Diagnostics Sales by Major Supplier
    Germany, PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: Italy, Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Estimated Cancer Death Rates Per 100,000 Population
    Italy, Laboratories Performing Tumor Marker Tests by Market Segment
    Italy, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
    Italy, Total Tumor Marker Test Volume Forecast by Market Segment
    Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecast
    Italy, Hospital Laboratories Major Tumor Marker Test Volume Forecast
    Italy, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    Italy, Total Tumor Marker Test Market Forecast by Market Segment
    Italy, All Market Segments Major Tumor Marker Sales Forecast by Test
    Italy, Hospital Laboratories Major Tumor Marker Forecast by Test
    Italy, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    Italy, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
    Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, CA-19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
    Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
    Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
    Italy, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, S-100 Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Total Tumor Markers Sales by Major Suppliers
    Italy, AFP Testing Market Diagnostics Sales by Major Supplier
    Italy, CEA Testing Market Diagnostics Sales by Major Supplier
    Italy, PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: Japan, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
    Japan, Estimated Cancer Death Rates Per 100,000 Population
    Japan, Laboratories Performing Tumor Marker Tests by Market Segment
    Japan, Hospital Laboratories Performing Tumor Marker Tests by Bed Size Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
    Japan, Total Tumor Marker Testing Volume Forecast by Market Segment
    Japan, All Market Segments Major Tumor Marker Test Volume Forecast
    Japan, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
    Japan, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    Japan, Total Tumor Marker Sales Forecast by Market Segment
    Japan, All Market Segments Major Tumor Marker Sales Forecast by Test
    Japan, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
    Japan, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    Japan, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
    Japan, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, TPA, Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Total Tumor Marker Sales by Major Suppliers
    Japan, AFP Testing Market Diagnostics Sales by Major Supplier
    Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
    Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
    Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
    Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
    Japan, PAP Testing Market Diagnostics Sales by Major Supplier
    Japan, PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
    Spain, Estimated Cancer Death Rates Per 100,000 Population
    Spain, Laboratories Performing Tumor Marker Tests by Market Segment
    Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
    Spain, Total Tumor Marker Test Volume Forecast by Market Segment
    Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast
    Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
    Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    Spain, Total Tumor Marker Sales Forecast by Market Segment
    Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
    Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
    Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, CA 15-3 Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecast by Market Segment
    Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, S-100 Protein Test Volume And Diagnostics Sales Forecast by Market Segment
    Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Total Tumor Marker Sales by Major Suppliers
    Spain, AFP Testing Market Diagnostics Sales by Major Supplier
    Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
    Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
    Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
    Spain, CEA Testing Market Diagnostics Sales by Major Supplier
    Spain, PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
    U.K., Estimated Cancer Death Rates Per 100,000 Population
    U.K., Laboratories Performing Tumor Marker Tests by Market Segment
    U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
    U.K., Total Tumor Marker Testing Volume Forecast by Market Segment
    U.K., All Market Segments Major Tumor Marker Test Volume Forecast
    U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
    U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    U.K., Total Tumor Marker Sales Forecast by Market Segment
    U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
    U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
    U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment
    U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Total Tumor Marker Sales and Market Shares Forecast
    U.K., CEA Testing Market Diagnostics Sales by Major Supplier
    U.K., PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: U.S., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
    U.S., Estimated New Cancer Cases and Deaths
    U.S., Estimated Cancer Death Rates Per 100,000 Population
    U.S., Laboratories Performing Tumor Marker Tests by Market Segment
    U.S., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    U.S., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
    U.S., Physician Office Laboratories Performing Tumor Marker Tests by Practice Size
    U.S., Total Tumor Marker Test Volume Forecast by Market Segment-201
    U.S., All Market Segments Major Tumor Marker Test Volume Forecast
    U.S., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
    U.S., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    U.S., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
    U.S., Cancer Clinics Major Tumor Marker Test Volume Forecast by Test
    U.S., Total Tumor Marker Sales Forecast by Market Segment
    U.S., All Market Segment Major Tumor Marker Sales Forecast by Test
    U.S., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
    U.S., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    U.S., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
    U.S., Cancer Clinics Major Tumor Marker Sales Forecast by Test
    U.S., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., CEA Test Volume and Diagnostics Sales by Market Segment
    U.S., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Colon-specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Total Tumor Marker Sales By Major Supplier
    U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
    U.S., AFP Testing Market Diagnostics Sales by Major Supplier
    U.S., Beta-2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
    U.S., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
    U.S., CA 19-9 Testing Market Diagnostics Sales by Major Supplier
    U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
    U.S., CEA Testing Market Diagnostics Sales by Major Supplier
    U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
    U.S., HCG Testing Market Diagnostics Sales by Major Supplier
    U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
    U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
    U.S., PAP Testing Market Diagnostics Sales by Major Supplier
    U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
    U.S., PSA Testing Market Diagnostics Sales by Major Supplier
    Skip to top


    Ask Your Question

    Future Horizons and Growth Strategies in the Global Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: